BioCryst Pharmaceuticals
BCRX
BCRX
165 hedge funds and large institutions have $635M invested in BioCryst Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 55 increasing their positions, 37 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
165
Holders Change
+31
Holders Change %
+23.13%
% of All Funds
3.39%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.06%
New
52
Increased
55
Reduced
37
Closed
21
Calls
$11.2M
Puts
$3.31M
Net Calls
+$7.88M
Net Calls Change
+$5.22M
Top Buyers
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
TSS
176
Two Sigma Securities
New York
| – | -$40K | -20,058 | Closed |
|
|
JG
177
Jefferies Group
New York
| – | -$38K | -18,829 | Closed |
|
178
Lazard Asset Management
New York
| – | -$35K | -17,523 | Closed |
|
|
C
179
Certuity
North Palm Beach,
Florida
| – | -$30K | -15,000 | Closed |
|
|
EGM
180
Engineers Gate Manager
New York
| – | -$20K | -10,000 | Closed |
|
|
ASN
181
Advisory Services Network
Atlanta,
Georgia
| – | -$11K | -5,700 | Closed |
|
|
MAM
182
Meeder Asset Management
Dublin,
Ohio
| – | -$2K | -1,015 | Closed |
|
|
SAM
183
S.A. Mason
Holland,
Michigan
| – | -$1K | -250 | Closed |
|